Beta Cell Action Launches to Advocate for Accessible Diabetes Care and Support Federal Legislation

Posted on by

LOS ANGELES, May 10, 2023 /PRNewswire/ — Beta Cell Action, a new 501(c)(4) organization dedicated to eliminating barriers to accessing insulin and other diabetes medications and devices, officially launches today. Beta Cell Action is the first and only diabetes-centered 501(c)(4) that is…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.